Aravive (ARAV) 8-K Unaudited quarterly results of operations

Exhibit 99.1

VERSARTIS, INC.

Unaudited quarterly results of operations

	Three Months Ended
	March 31			June 30			September 30			December 31
2013:
Operating expenses
Research and development	$	3,499		$	3,326		$	4,576		$	3,454
General and administrative		682			656			685		$	2,405
Total operating expenses		4,181			3,982			5,261			5,859
Loss from operations		(4,181	)		(3,982	)		(5,261	)		(5,859	)
Net loss attributable to common stockholders	$	(4,019	)	$	(3,655	)	$	(5,009	)	$	(5,814	)
Net loss per basic and diluted share attributable to common stockholders	$	(30.23	)	$	(24.74	)	$	(19.98	)	$	(4.62	)
2012:
Operating expenses
Research and development	$	2,425		$	3,113		$	2,456		$	2,969
General and administrative		376			465			564		$	531
Total operating expenses		2,801			3,578			3,020			3,500
Loss from operations		(2,801	)		(3,578	)		(3,020	)		(3,500	)
Net loss attributable to common stockholders	$	(2,758	)	$	(3,546	)	$	(3,016	)	$	(3,897	)
Net loss per basic and diluted share attributable to common stockholders	$	(26.43	)	$	(32.94	)	$	(27.18	)	$	(33.02	)